The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Agios Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Agios Pharmaceuticals opposed by its competitors

Explore Agios Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3307271
Sep 13, 2023Methods Of Using Pyruvate Kinase Activators2
EP3713919
Aug 2, 2023Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide2

Latest PTAB cases involving Agios Pharmaceuticals

Discover the latest PTAB cases involving Agios Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Agios Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AGIOS PHARMACEUTICALS - 4 - -
BOTTI & FERRARI14 - - -
SANDOZ1191619 -